DK1406616T3 - Injicerbar galenisk formulering til anvendelse i en fotodynamisk diagnose eller terapi, og fremgangsmåde til dens fremstilling - Google Patents

Injicerbar galenisk formulering til anvendelse i en fotodynamisk diagnose eller terapi, og fremgangsmåde til dens fremstilling

Info

Publication number
DK1406616T3
DK1406616T3 DK02747627T DK02747627T DK1406616T3 DK 1406616 T3 DK1406616 T3 DK 1406616T3 DK 02747627 T DK02747627 T DK 02747627T DK 02747627 T DK02747627 T DK 02747627T DK 1406616 T3 DK1406616 T3 DK 1406616T3
Authority
DK
Denmark
Prior art keywords
photosensitizer
therapy
preparation
photodynamic diagnosis
galenic formulation
Prior art date
Application number
DK02747627T
Other languages
English (en)
Inventor
Pierre-Herve Brun
Alain Prudhomme
Jean-Luc Barnoux
Original Assignee
Steba Biotech N V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Steba Biotech N V filed Critical Steba Biotech N V
Application granted granted Critical
Publication of DK1406616T3 publication Critical patent/DK1406616T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK02747627T 2001-07-17 2002-07-05 Injicerbar galenisk formulering til anvendelse i en fotodynamisk diagnose eller terapi, og fremgangsmåde til dens fremstilling DK1406616T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01810708A EP1277470A1 (fr) 2001-07-17 2001-07-17 Formulation galénique injectable pour utilisation dans un diagnostic ou une thérapie photodynamique et son procédé de préparation
PCT/IB2002/002661 WO2003009842A1 (fr) 2001-07-17 2002-07-05 Formulation galenique injectable pour utilisation dan un diagnostic ou une therapie photodynamique et son procede de preparation

Publications (1)

Publication Number Publication Date
DK1406616T3 true DK1406616T3 (da) 2008-01-21

Family

ID=8184036

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02747627T DK1406616T3 (da) 2001-07-17 2002-07-05 Injicerbar galenisk formulering til anvendelse i en fotodynamisk diagnose eller terapi, og fremgangsmåde til dens fremstilling

Country Status (20)

Country Link
US (1) US20040147500A1 (da)
EP (2) EP1277470A1 (da)
JP (1) JP2004537562A (da)
CN (1) CN1303999C (da)
AT (1) ATE372769T1 (da)
BR (1) BR0211173A (da)
CA (1) CA2454150A1 (da)
DE (1) DE60222421T2 (da)
DK (1) DK1406616T3 (da)
ES (1) ES2292781T3 (da)
HU (1) HUP0400754A3 (da)
IL (1) IL159620A0 (da)
MX (1) MXPA04000042A (da)
NO (1) NO20040216L (da)
NZ (1) NZ530634A (da)
PL (1) PL368503A1 (da)
PT (1) PT1406616E (da)
RU (1) RU2278665C2 (da)
WO (1) WO2003009842A1 (da)
ZA (1) ZA200400328B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7825153B2 (en) * 2004-08-16 2010-11-02 Ceramoptec Industries, Inc. Photosensitizer formulations and their use
KR100866728B1 (ko) * 2004-11-12 2008-11-03 주식회사종근당 타크로리무스를 함유하는 주사제
EP2008665A1 (fr) * 2007-06-25 2008-12-31 Steba Biotech N.V. Formulation injectable pour thérapie photodynamique
RU2565766C1 (ru) * 2014-11-17 2015-10-20 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии и регенеративной медицины имени Е.Л. Гольдберга" 4-(3,4-дибромтиофенкарбонил)-2,6,8,12-тетраацетил-2,4,6,8,10,12-гексаазатетрацикло[5,5,0,03,11,05,9]додекан в качестве анальгетического средства и способ его получения
EP3225112B1 (de) * 2016-04-01 2021-08-18 TriOptoTec GmbH Photosensibilisator-dispersion und verwendung derselben
CN108670950B (zh) * 2018-06-29 2020-10-02 深圳海王医药科技研究院有限公司 一种不含有机溶剂的虎杖苷药物组合物及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2963178B2 (ja) * 1990-09-27 1999-10-12 株式会社エス・エル・ティ・ジャパン 水溶性フェオホーバイドａの製造方法
US5654423A (en) * 1990-11-21 1997-08-05 Regents Of The University Of California Boronated metalloporphyrine and therapeutic methods
EP0675955A1 (en) * 1992-12-23 1995-10-11 Iowa State University Research Foundation, Inc. Molecular flashlight
US6147195A (en) * 1993-07-26 2000-11-14 Yeda Research And Development Co., Ltd. Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them
US5462726A (en) * 1993-12-17 1995-10-31 Bristol-Myers Squibb Company Method of inhibiting side effects of solvents containing ricinoleic acid or castor oil or derivatives thereof employing a thromboxane A2 receptor antagonist and pharmaceutical compositions containing such solvents
US5616342A (en) * 1995-04-11 1997-04-01 Pdt, Inc. Emulsioin suitable for administering a poorly water-soluble photosensitizing compound and use thereof
IL116126A0 (en) * 1995-11-24 1996-01-31 Yeda Res & Dev Process for the preparation of bacteriochlorophyllis some novel compounds of this type and pharmaceutical compositions comprising them
WO2000033833A1 (en) * 1998-12-09 2000-06-15 Yeda Research And Development Co. Ltd. Palladium-substituted bacteriochlorophyll derivatives and use thereof

Also Published As

Publication number Publication date
WO2003009842A1 (fr) 2003-02-06
ATE372769T1 (de) 2007-09-15
RU2004104469A (ru) 2005-04-20
RU2278665C2 (ru) 2006-06-27
BR0211173A (pt) 2004-08-10
HUP0400754A2 (hu) 2004-07-28
NO20040216L (no) 2004-03-17
EP1406616A1 (fr) 2004-04-14
IL159620A0 (en) 2004-06-01
JP2004537562A (ja) 2004-12-16
WO2003009842A8 (fr) 2004-04-01
HUP0400754A3 (en) 2005-11-28
NZ530634A (en) 2006-11-30
EP1277470A1 (fr) 2003-01-22
CA2454150A1 (fr) 2003-02-06
CN1303999C (zh) 2007-03-14
PL368503A1 (en) 2005-04-04
DE60222421D1 (de) 2007-10-25
ZA200400328B (en) 2004-09-13
US20040147500A1 (en) 2004-07-29
ES2292781T3 (es) 2008-03-16
PT1406616E (pt) 2007-12-20
MXPA04000042A (es) 2005-08-16
EP1406616B1 (fr) 2007-09-12
DE60222421T2 (de) 2008-06-05
CN1529594A (zh) 2004-09-15

Similar Documents

Publication Publication Date Title
ES2620413T3 (es) Formulaciones veterinarias antihelmínticas tópicas
JP4804431B2 (ja) 長時間作用オキシテトラサイクリン組成物
ES2193658T3 (es) Procedimiento para la preparacion de formulaciones acuosas para uso oftalmico.
EP1158959A4 (en) COMPOSITIONS AND METHODS FOR IMPROVED DELIVERY OF HYDROPHOBIC THERAPEUTIC AGENTS
KR970704472A (ko) 수성 리스페리돈 제제(aqueous risperidone formulations)
RU94045798A (ru) Стереоизомеры итраконазола или саперконазола, способ их получения, их комплексы и способ получения, фармацевтическая композиция на их основе и ее получение, способ получения водных растворов с повышенной концентрацией итраконазола или саперконазола
DK1406616T3 (da) Injicerbar galenisk formulering til anvendelse i en fotodynamisk diagnose eller terapi, og fremgangsmåde til dens fremstilling
HUP0202749A2 (hu) Levoszimendánt tartalmazó oldat formájú gyógyszerkészítmény
GR3005398T3 (da)
KR850001198A (ko) 카복실산 유도체의 제조방법
KR960000225A (ko) 기관지천식 치료제
EE04264B1 (et) Naatriumkloriidi kasutamine aine valmistamiseks kamptotetsiini derivaatide manustamisest tingitud gastrointestinaalsete kõrvaltoimete vähendamiseks
WO2004095921A3 (en) Sporicidal composition
JP4754149B2 (ja) 水性液剤
CA2244085A1 (en) Therapeutic anti-asthma agents containing selenium compounds
US5814635A (en) Concentrated injection solution of alkali metal salts of reduced folates
RU2005117626A (ru) Улучшенные готовые лекарственные формы, содержащие замещенные производные имидазола
JP2822049B2 (ja) 水性製剤組成物
WO2003013380A3 (en) Multi-part dental bleaching systems and method for bleaching teeth using such systems
HUP0301334A2 (hu) Szubsztituált akriloil-disztamicin-származékokat és taxánokat és/vagy antimetabolitokat tartalmazó kombinált tumorellenes kompozíciók
JPS5527133A (en) Drug comprising organosilicon compound as main constituent
JPH0283323A (ja) 安定な酪酸リボフラビン水溶液
EP0021847B1 (en) Long acting sulfonamide injectable compositions
IE49933B1 (en) Sulfonamide solutions
KR910000121A (ko) 피리도 [1,2-a] 피리미딘 화합물의 수성제제